Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation

Journal of Immunology

Volumn 178, Issue 2, 2007, Pages 647-651

  Carr, William H ^a   Rosen, David B ^a   Arase, Hisashi ^b,c   Nixon, Douglas F ^d   Michaelsson, Jakob ^e   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA B ANTIGEN; IMMUNOGLOBULIN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE COURSE; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPRECIPITATION; KIR3DS1 GENE; LYMPHOID CELL; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33846200446     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.2.647     Document Type: Article

References (24)

1. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31: 429-434.
2. Lopez-Vazquez, A., A. Mina-Blanco, J. Martinez-Borra, P. D. Njobvu, B. Suarez-Alvarez, M. A. Bianco-Gelaz, S. Gonzalez, L. Rodrigo, and C. Lopez-Larrea. 2005. Interaction between KIR3DL1 and HLA-B*57 supertype alleies influences the progression of HIV-1 infection in a Zambian population. Hum. Immunol. 66: 285-289.
3. Dohring, C., J. Samaridis, and M. Colonna. 1996. Alternatively spliced forms of human killer inhibitory receptors. Immunogenetics 44: 227-230.
4. Norman, P. J., H. A. Stephens, D. H. Verity, D. Chandanayingyong, and R. W. Vaughan. 2001. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 52: 195-205.
5. Norman, P. J., and P. Parham. 2005. Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors. Semin. Hematol. 42: 65-75.
6. Williams, F., L. D. Maxwell, I. A. Halfpenny, A. Meenagh, C. Sleator, M. D. Curran, and D. Middleton. 2003. Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals. Hum. Immunol. 64: 729-732.
7. Campbell, K. S., M. Cella, M. Carretero, M. Lopez-Botet, and M. Colonna. 1998. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur. J. Immunol. 28: 599-609.
8. Olcese, L., A. Cambiaggi, G. Semenzato, C. Bottino, A. Moretta, and E. Vivier. 1997. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 158: 5083-5086.
9. Lanier, L. L., B. C. Corliss, J. Wu, C. Leong, and J. H. Phillips. 1998. Immunoreceptor DAP12 bearing a tyro sine-based activation motif is involved in activating NK cells. Nature 391: 703-707.
10. Gumperz, J. E., V. Litwin, J. H. Phillips, L. L. Lanier, and P. Parham. 1995. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181: 1133-1144.
11. Carr, W. H., M. J. Pando, and P. Parham. 2005. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175: 5222-5229.
12. Gilfillan, S., E. L. Ho, M. Cella, W. M. Yokoyama, and M. Colonna. 2002. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3: 1150-1155.
13. Onishi, M., S. Kinoshita, Y. Morikawa, A. Shibuya, J. Phillips, L. L. Lanier, D. M. Gorman, G. P. Nolan, A. Miyajima, and T. Kitamura. 1996. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24: 324-329.
14. Uhtberg, M., N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L. L. Lanier, and P. Patham. 1997. Human diversity in killet cell inhibitory teceptot genes. Immunity 7: 753-763.
15. Imai, C., S. Iwamoto, and D. Campana. 2005. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood 106: 376-383.
16. Rosen, D. B., M. Araki, J. A. Hamerman, T. Chen, T. Yamamura, and L. L. Lanier. 2004. A Structural basis for the association of DAP12 with mouse, but not human, NKG2D. J. Immunol. 173: 2470-2478.
17. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
18. Robertson, M. J., K. J. Cochran, C. Cameron, J. M. Le, R. Tantravahi, and J. Ritz. 1996. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24: 406-415.
19. Vitale, M., S. Sivori, D. Pende, R. Augugliaro, C. Di Donato, A. Amoroso, M. Malnati, C. Bottino, L. Moretta, and A. Moretta. 1996. Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc. Natl. Acad. Sci. USA 93: 1453-1457.
20. Biassoni, R., M. Palco, A. Cambiaggi, P. Costa, S. Verdiani, D. Pende, R. Conte, C. Di Donato, P. Parham, and L. Moretta. 1995. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules: role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J. Exp. Med. 182: 605-609.
21. Rajagopalan, S., and E. O. Long. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185: 1523-1528.
22. Peruzzi, M., N. Wagtmann, and E. O. Long. 1996. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 184: 1585-1590.
23. Hansasuta, P., T. Dong, H. Thananchai, M. Weekes, C. Willberg, H. Aldemir, S. Rowland-Jones, and V. M. Braud. 2004. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur. J. Immunol. 34: 1673-1679.
24. Qi, Y., M. P. Martin, X. Gao, L. Jacobson, J. J. Goedert, S. Buchbinder, G. D. Kirk, J. O'Brien S. J. Trowsdale, and M. Carrington. 2006. KIR/HLA pleiorropism: protection against both HIV and opportunistic infections. PLoS Pathog. 2: e79.